To Compare the Safety and Pharmacokinetics of PT105 With PT105R in Healthy Postmenopausal Female Volunteers
NCT04783636 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2021-03-17
Summary
The purpose of study is to compare the safety and pharmacokinetics of PT105 with PT105R in healthy postmenopausal female volunteers
Conditions
Interventions
- DRUG
-
leuprorelin acetate 3.75mg
PT105, PT105R
Sponsors & Collaborators
-
Peptron, Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 19 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-03-11
- Primary Completion
- 2021-07-20
- Completion
- 2021-07-20
More Related Trials
-
Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer
NCT01077453 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Breast Cancer Prevention by Letrozole in High Risk Women
NCT00579826 ·Status: COMPLETED ·Phase: PHASE2
-
Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer
NCT00237211 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer
NCT00267553 ·Status: TERMINATED ·Phase: PHASE3
-
Protocol for Women at Increased Risk of Developing Breast Cancer
NCT00291135 ·Status: COMPLETED ·Phase: PHASE2
-
Letrozole in Preventing Breast Cancer in Postmenopausal Women
NCT00090857 ·Status: COMPLETED ·Phase: PHASE2
-
Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers
NCT00535418 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction
NCT00213148 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer
NCT00530868 ·Status: COMPLETED ·Phase: PHASE2
-
Letrozole in Treating Postmenopausal Women With Metastatic Breast Cancer
NCT00014638 ·Status: COMPLETED ·Phase: PHASE4
-
Extended Adjuvant Treatment With Letrozole in Breast Cancer Who Complete 5 Years of Toremifene
NCT01072318 ·Status: UNKNOWN ·Phase: PHASE4
-
Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer
NCT00247663 ·Status: COMPLETED ·Phase: PHASE2
-
Aromatase Inhibitor Host Factors Study
NCT01669343 ·Status: COMPLETED ·Phase: NA
-
Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma
NCT00847366 ·Status: COMPLETED ·Phase: NA
-
Leuprorelin Associated With Radiotherapy Versus Leuprorelin Alone in T3 - T4 or pT3 (on Biopsy) N0, M0 Prostate Cancer
NCT01122121 ·Status: COMPLETED ·Phase: PHASE3
-
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
NCT00553410 ·Status: COMPLETED ·Phase: PHASE3
-
Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.
NCT00171340 ·Status: COMPLETED ·Phase: PHASE3
-
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
NCT06016738 ·Status: RECRUITING ·Phase: PHASE3
-
Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density
NCT00238316 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer
NCT00083993 ·Status: TERMINATED ·Phase: PHASE3
-
RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast Cancer
NCT01208441 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of Predictive Factors Regarding the Effectivity of Aromatase Inhibitor Therapy (PreFace)
NCT01908556 ·Status: UNKNOWN ·Phase: PHASE4
-
Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy
NCT00754845 ·Status: COMPLETED ·Phase: PHASE3
-
Letrozole in Postmenopausal Women at Increased Risk for Breast Cancer
NCT00280930 ·Status: UNKNOWN ·Phase: PHASE2
-
Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer
NCT00332852 ·Status: COMPLETED ·Phase: PHASE3